期刊文献+

二甲双胍治疗多囊卵巢综合征的临床研究 被引量:1

Effects of Metformin on Treating Polycystic Ovary Syndrome
下载PDF
导出
摘要 目的:探讨二甲双胍在治疗多囊卵巢综合征的临床效果。方法:30例多囊卵巢综合征(PCOS)患者,口服二甲双胍12周,采取自身对照,观察用药前、后临床症状、血清卵泡刺激素(FSH)、黄体生成激素(LH)、睾酮(T)、雄烯二酮(A2)、空腹血糖及空腹胰岛素水平的变化。结果:继发闭经13例中,7例恢复有排卵月经;月经稀发17例,10例恢复有排卵月经,不孕症16例,用药期间妊娠4例。用药后两组空腹胰岛素和雄激素水平均降低,比较差异有显著性(P<0.05)。结论:二甲双胍可有效改善PCOS患者的胰岛素抵抗状态,降低血中雄激素水平并恢复生育功能。 Objective: To investigate the clinical effects of metformin on treating women with polycystic ovary syndrome (P-COS). Methods; 30 of patients took orally metformin for 12 weeks. Clinical symptoms, FSH, LH, T, A2, glucose and insulin were measured before and after taking metformin. Results: Of 13 women with secondary amenorrhea, 7 got back catame-nia. 10 had catamenia again among 17 women with oligomenorrhea. 4 had a pregnancy in 16 of women with infertility. The content of insulin and androgen was less than that before taking medicine, and there was significant difference (P <0. 05). Conclusion: Metformin is effective to reduce the content of insulin and androgen and to recover ovulation in women with PCOS.
出处 《中国计划生育学杂志》 2004年第8期483-485,共3页 Chinese Journal of Family Planning
关键词 二甲双胍 治疗 多囊卵巢综合征 月经 空腹胰岛素 雄激素 PCOS 排卵 用药期 雄烯二酮 Metformin Polycystic ovary syndrome Hyperinsulinemia
  • 相关文献

参考文献9

二级参考文献17

  • 1王蔼明,中华妇产科杂志,1998年,33卷,280页 被引量:1
  • 2石湘芸,体液因素与临床疾病,1997年,296页 被引量:1
  • 3la Marca A, Morgante G, Paglia T, et al. Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome. Fertil Steril, 1999,72:985-989. 被引量:1
  • 4Velazquez EM, Mendoza SG, Wang P, et al. Metformin therapy is associated with decrease in plasma plasminogen activator inhibitor-1,lipoprotein(a),and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism, 1997,46: 454-457. 被引量:1
  • 5Velazquez E, Acosta A, Mendoza SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol, 1997,90:392-395. 被引量:1
  • 6Glueck CJ, Wang P, Fontaine R,et al. Metformin-induced resumption of normal menses in 39 of 43(91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism, 1999,48:511-519. 被引量:1
  • 7Glueck CJ. Pregnancy failure and preservation in women with polycystic ovary syndrome: safety and efficacy of metformin therapy continued through pregnancy. Experimental Biology, 2000, (4): 16-18. 被引量:1
  • 8Acbay O, Gundogdu S. Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril, 1996, 65: 946-949. 被引量:1
  • 9Ehrmann DA, Cavaghan M,Imperial J,et al. Effects of metformin on insulin secretion, insulin action and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1997, 82:524-530. 被引量:1
  • 10Glueck CJ, Wang P, Fontaine RN,et al. Plasminogen activator inhibitor activity:an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism,1999,48:1589-1595. 被引量:1

共引文献131

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部